Zavegepant

Zavegepant is a highly effective and selective small molecule CGRP receptor antagonist. It is the first and only CGRP receptor antagonist for intranasal administration and is currently being developed for the treatment of acute migraine.

Price Not Available Please inquire Zavegepant Supplier Page

Catalog Number	1337918-83-8
Alternative Name(s)	BMS-742413; BHV-3500; Vazegepant
Molecular Formula	C139H230N44O38·xCF3COOH
CAS#	1337918-83-8
Purity	≥98%
Inchi	InChI=1S/C36H46N8O3/c1-24-19-25(20-28-23-37-40-33(24)28)21-32(35(46)43-17-15-42(16-18-43)29-9-11-41(2)12-10-29)39-36(47)44-13-7-26(8-14-44)30-22-27-5-3-4-6-31(27)38-34(30)45/h3-6,19-20,22-23,26,29,32H,7-18,21H2,1-2H3,(H,37,40)(H,38,45)(H,39,47)/t32-/m1/s1
Inchi Key	JJVAPHYEOZSKJZ-JGCGQSQUSA-N
Size	Please inquire
Supplier Page	https://www.bocsci.com/product/zavegepant-cas-1337918-83-8-373135.html